Bottom line
LHCAX vs HRTS: the short answer
LHCAX (Lord Abbett Health Care Fund) and HRTS (Tema Heart & Health ETF) are both mutual funds.
HRTS is cheaper at 0.75% vs 1.03% — a difference of $28 a year per $10,000 invested.
Over one year, HRTS returned +23.6% vs +10.9% for LHCAX.
LHCAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
LHCAX vs HRTS side by side
| LHCAX | HRTS | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Lord Abbett | Innovator |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.03% | 0.75% |
| Annual cost per $10k | $103 | $75 |
| 10-yr cost on $10k (prospectus) | $3,961 | $1,168 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +10.9% | +23.6% |
| 5-yr return (annualized) | +3.1% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +21.5% | +15.8% |
| Worst quarter | −11.4% | −12.4% |
| Net assets (fund) | $8.6M | $51.9M |
| Number of holdings | 61 | 45 |
| Portfolio turnover | 91% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LHCAX | HRTS | Difference |
|---|---|---|---|
| 2025 | +17.7% | +23.6% | −6.0% |
| 2024 | +7.3% | +3.6% | +3.7% |
Source: Fund prospectus bar charts
Holdings overlap
11 of LHCAX's top 25 holdings also appear in HRTS's top 25.
| Holding | LHCAX | HRTS |
|---|---|---|
| Eli Lilly & Co | 10.40% | 11.52% |
| UnitedHealth Group Inc | 5.39% | 5.24% |
| Johnson & Johnson | 4.96% | 3.59% |
| Novartis AG | 4.19% | 3.38% |
| Gilead Sciences Inc | 3.53% | 3.43% |
| Thermo Fisher Scientific Inc | 2.31% | 3.97% |
| Vertex Pharmaceuticals Inc | 2.24% | 2.93% |
| AstraZeneca PLC | 1.97% | 4.00% |
| Bridgebio Pharma Inc | 1.84% | 2.59% |
| Edwards Lifesciences Corp | 1.78% | 1.75% |
| Revolution Medicines Inc | 1.67% | 3.33% |
Source: SEC Form N-PORT
LHCAX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
FAQ
What is the difference between LHCAX and HRTS?
Which is cheaper, LHCAX or HRTS?
Should I own both LHCAX and HRTS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.